Quick Answer
Immunome Inc. reported Shares Outstanding of 113.13 million shares for fiscal year 2025.
Immunome Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 113.13M | +75.5% |
| 2024 | 64.46M | +49.0% |
| 2023 | 43.25M | +256.6% |
| 2022 | 12.13M | +0.2% |
| 2021 | 12.11M | +13.9% |
| 2020 | 10.63M | +867.4% |
| 2019 | 1.10M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 91.71M | +51.8% | +5.4% |
| June 30, 2025 | 87.01M | +45.0% | +0.1% |
| March 31, 2025 | 86.96M | +45.7% | +34.9% |
| December 31, 2024 | 64.46M | +49.0% | +6.7% |
| September 30, 2024 | 60.42M | +395.2% | +0.7% |
| June 30, 2024 | 60.01M | +391.9% | +0.5% |
| March 31, 2024 | 59.69M | +389.5% | +38.0% |
| December 31, 2023 | 43.25M | +256.6% | +254.4% |
- Immunome Inc. showed an increase of +75.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Immunome Inc.’s shares outstanding has grown by 10191.7% (from 1.10 million shares to 113.13 million shares).
- The most recent figure is from Immunome Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: